IHRD-46
Response
Accepted
Self-assessed
Clinician Attendance at Post-Mortem Discussions
Recommendation
Where possible, treating clinicians should attend for clinico-pathological discussions at the time of post-mortem examination and thereafter upon request.
Published Evidence Summary
The following publicly available evidence relates to this recommendation:
According to the Department of Health Northern Ireland's Implementation Programme, this recommendation was completed as of January 2024. According to the government's response in March 2018, guidance was issued regarding clinician attendance at clinico-pathological discussions (Department of Health NI, 2024; health-ni.gov.uk, 2018).
How was this assessed?
Assessed by gemini-2.5-flash on 19 Mar 2026
Checked data held on this site (government responses, progress updates, independent evidence)
External sources searched: www.gov.uk, www.health-ni.gov.uk, www.legislation.gov.uk, hansard.parliament.uk
This recommendation requires implementation across many organisations. The assessment reflects central policy response, not adoption in individual organisations.
Jurisdiction
Northern Ireland
Response
Accepted
Response
Accepted
Accepted
HSC Trusts
01 Mar 2018
Guidance issued on clinician attendance at clinico-pathological discussions.
Source
Inquiry
Hyponatraemia Inquiry
Report
Report of the Inquiry into Hyponatraemia-related Deaths
31 Jan 2018
Responsible Bodies
HSC Trusts
Primary
Themes & Tags
Recommendation age
8.1 yrs
Last formal update
783 days ago